Long Wenyong, Yi Yang, Chen Shen, Cao Qi, Zhao Wei, Liu Qing
Department of Neurosurgery, Xiangya Hospital, Central South UniversityChangsha, China.
Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-sen UniversityGuangzhou, China.
Front Pharmacol. 2017 Jul 25;8:495. doi: 10.3389/fphar.2017.00495. eCollection 2017.
Diffuse intrinsic pontine glioma (DIPG) is an extensively invasive malignancy with infiltration into other regions of the brainstem. Although large numbers of specific targeted therapies have been tested, no significant progress has been made in treating these high-grade gliomas. Therefore, the identification of new therapeutic approaches is of great importance for the development of more effective treatments. This article reviews the conventional therapies and new potential therapeutic approaches for DIPG, including epigenetic therapy, immunotherapy, and the combination of stem cells with nanoparticle delivery systems.
弥漫性脑桥内在型胶质瘤(DIPG)是一种具有广泛侵袭性的恶性肿瘤,可浸润至脑干的其他区域。尽管已经测试了大量特定的靶向治疗方法,但在治疗这些高级别胶质瘤方面尚未取得显著进展。因此,确定新的治疗方法对于开发更有效的治疗方案至关重要。本文综述了DIPG的传统治疗方法和新的潜在治疗方法,包括表观遗传治疗、免疫治疗以及干细胞与纳米颗粒递送系统的联合应用。